These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 34046909)

  • 1. Non-alcoholic fatty liver disease: raising awareness of a looming public health problem.
    Gracen L; Powell EE
    Med J Aust; 2021 Jul; 215(2):75-76. PubMed ID: 34046909
    [No Abstract]   [Full Text] [Related]  

  • 2. A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe.
    Lazarus JV; Ekstedt M; Marchesini G; Mullen J; Novak K; Pericàs JM; Roel E; Romero-Gómez M; Ratziu V; Tacke F; Cortez-Pinto H; Anstee QM;
    J Hepatol; 2020 Jan; 72(1):14-24. PubMed ID: 31518646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].
    Halmos T; Suba I
    Orv Hetil; 2017 Dec; 158(52):2051-2061. PubMed ID: 29285942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of visceral fat and fatty liver disease using ultrasound in patients with diabetes.
    Onitsuka Y; Takeshima F; Ichikawa T; Kohno S; Nakao K
    Intern Med; 2014; 53(6):545-53. PubMed ID: 24633023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
    García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
    Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
    ; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
    Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease: A growing public health problem in Turkey.
    Kaya E; Yılmaz Y
    Turk J Gastroenterol; 2019 Oct; 30(10):865-871. PubMed ID: 31258135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes.
    Mantovani A
    Liver Int; 2019 Apr; 39(4):779. PubMed ID: 30548562
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Mantovani: "Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes".
    Zaccardi F; Morrison AE; Khunti K; Davies MJ
    Liver Int; 2019 Apr; 39(4):780-781. PubMed ID: 30615269
    [No Abstract]   [Full Text] [Related]  

  • 14. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of non-alcoholic fatty liver disease: Polish-case control study.
    Kempiński R; Łukawska A; Krzyżanowski F; Ślósarz D; Poniewierka E
    Adv Clin Exp Med; 2019 Dec; 28(12):1615-1620. PubMed ID: 31025557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction.
    Federico A; Dallio M; Masarone M; Persico M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4731-4741. PubMed ID: 27906428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Nonalcoholic fatty liver disease without obesity: the problem to be solved].
    Bueverov AO; Bogomolov PO
    Ter Arkh; 2017; 89(12. Vyp. 2):226-232. PubMed ID: 29488485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
    Rivera-Andrade A; Kroker-Lobos MF; Lazo M; Freedman ND; Smith JW; Torres O; McGlynn KA; Groopman JD; Guallar E; Ramirez-Zea M
    Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):191-200. PubMed ID: 30573307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol efflux capacity is impaired in subjects with an elevated Fatty Liver Index, a proxy of non-alcoholic fatty liver disease.
    van den Berg EH; Gruppen EG; Ebtehaj S; Bakker SJL; Tietge UJF; Dullaart RPF
    Atherosclerosis; 2018 Oct; 277():21-27. PubMed ID: 30170220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-Metabolic Disorders in Non-Alcoholic Fatty Liver Disease.
    El Hadi H; Di Vincenzo A; Vettor R; Rossato M
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31064058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.